1. Which of the following is the dry eye disease (DED)-associated autoimmune disorder characterized by inflammatory changes in the lacrimal and salivary glands:
A. Rheumatoid arthritis
B. Scleroderma
C. Sjogren syndrome
D. Systemic lupus erythematosus
2. Which of the following is not a side effect of topical corticosteroid eye drops:
A. Glaucoma
B. Cataracts
C. Increased risk of infection
D. Myopia
3. Which of the following actions constitutes the rationale for recommending omega-3 fatty acids for the treatment of DED:
A. Antibiotic
B. Anticholinergic
C. Anti-inflammatory
D. Cholinergic
4. The most common source of evaporative dry eye is
A. Cigarette smoking
B. Extended time at computer terminals
C. Grave's disease
D. Meibomian gland dysfunction
5. The highest correlation between DED and the use of hormone replacement therapy for women occurs with:
A. Estrogen alone
B. Estrogen and progesterone
C. No hormone replacement therapy
D. Progesterone alone
6. Deleterious effects on the tear film, cornea, and conjunctiva are most strongly correlated with which of the following:
A. Benzalkonium chloride
B. Disodium EDTA
C. Sodium chlorite
D. Sodium perborate
7. Which of the following is categorized as a “vanishing” preservative:
A. Benzalkonium chloride
B. Disodium EDTA
C. Sodium perborate
D. Polyquaternium-1 (Polyquad)
8. Which class of antibiotics may be useful for the treatment of unresponsive, severe DED?
A. Cephalosporins
B. Fluoroquinolones
C. Penicillins
D. Tetracyclines
9. If a patient is using both ocular drops and a gel or ointment, the proper order for administration is
A. Drops followed immediately by ointment or gel
B. Drops followed by ointment or gel 10 minutes later
C. Ointment or gel immediately followed by drops
D. Ointment or gel followed by drops 10 minutes later
10. The pharmacist should always refer a patient to an eye care specialist for
A. Moderate-to-severe ocular pain
B. Questions about how to administer an ocular drug
C. Questions about insurance coverage for medications
D. Transient itching or burning
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. To what extent did the program meet objective #6?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. To what extent did the program meet objective #7?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
24. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
25. Will the information presented cause you to change your practice?
A. Yes
B. No
26. Are you committed to making these changes?
A. Yes
B. No
27. As a result of this activity, did you learn something new?
A. Yes
B. No
28. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology/Specialty Pharmacy
I. Industry/Manufacturing
29. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20